🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2015-01-01
Trial ID
NCT06711055
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
Adult men and women with early-stage, IHC/FISH-defined HER2-positive breast...
Status
Recruiting
Location
University of Illinois
Start Date
2024-12-05
Trial ID
NCT06441890
Treatments Being Tested
A Single-Center Retrospective Study About Efficacy and Safety of Eribulin-B...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-02-01
Trial ID
NCT05953909
Treatments Being Tested
The aim of evaluating the efficacy and safety of cadonilimab combined with ...
Status
Recruiting
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
Start Date
2024-03-01
Trial ID
NCT06467500
Treatments Being Tested
This prospective, single-arm, exploratory, phase II study was designed to e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-15
Trial ID
NCT06714266
Treatments Being Tested
At present, the incidence rate of breast cancer has exceeded that of lung c...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2023-05-03
Trial ID
NCT05918328
Treatments Being Tested
This phase II trial compares cabozantinib alone and the combination of cabo...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Start Date
2020-07-13
Trial ID
NCT04310007